Risk factors for developing post‐thymectomy myasthenia gravis in patients with thymoma. Issue 4 (15th February 2021)

• Record Type: Journal Article
• Authors: Kim, Ahwon; Choi, Seok‐Jin; Kang, Chang Hyun; Lee, Seonkyung; Son, Hyoshin; Kim, Jin‐Ah; Shin, Je‐Young; Kim, Sung‐Min; Hong, Yoon‐Ho; Sung, Jung‐Joon
• Is Part Of: Muscle & nerve. Volume 63:Issue 4(2021)
• Page Start: 531
• Page End: 537
• Publication Date: 2021-02-15
• Subjects: anti‐acetylcholine receptor antibody -- myasthenia gravis -- post‐thymectomy -- thymectomy -- thymoma; Neuromuscular diseases -- Periodicals; Muscles -- Periodicals; Nerves -- Periodicals; 616.74
• DOI: 10.1002/mus.27169
• Languages: English
• ISSNs: 0148-639X

Abstract

Abstract: Background: Thymectomy is required for the treatment of thymoma‐associated myasthenia gravis (MG). However, MG may develop only after thymectomy, a condition known as post‐thymectomy MG. This study aimed to investigate the risk factors for post‐thymectomy MG in patients with thymoma. Methods: We retrospectively identified 235 patients with thymoma who underwent thymectomy at a single hospital from January 2008 to December 2017: 44 with preoperatively diagnosed MG were excluded, leaving 191 patients in the final analysis. Univariable survival analyses using Cox proportional hazards regression model and Kaplan‐Meier estimate were conducted to identify risk factors for post‐thymectomy MG. Results: Post‐thymectomy MG developed in 4.2% (8/191) of the patients with thymoma between 18 days and 108 mo after surgery. Hazard ratios (HRs) of pre‐ and postoperative anti‐acetylcholine receptor antibody (AChR‐Ab) titers were 2.267 ( P = .002) and 1.506 ( P < .001), respectively. Patients with extended thymectomy had a low chance of post‐thymectomy MG (HR 0.035, P = .007). Larger thymoma (HR, 1.359; P = .005) and type A or AB thymoma according to World Health Organization histological classification (HR, 11.92; P = .021) were associated with higher chances of post‐thymectomy MG. Within the subgroup of preoperatively AChR‐Ab seropositive patients, post‐thymectomy MG developed in 22.2% (6/27). Conclusions: Pre‐ and postoperative AChR‐Ab levels should be measured in patients with thymoma. A large thymoma and partial thymectomy appear to be associated with a higher probability of post‐thymectomy MG.